Home/Filings/4/0001702824-26-000002
4//SEC Filing

Bell Michael Brian 4

Accession 0001702824-26-000002

CIK 0001576280other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:57 PM ET

Size

20.9 KB

Accession

0001702824-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-01
Bell Michael Brian
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-01+10,52040,185 total
  • Exercise/Conversion

    Common Stock

    2026-01-01+3,32443,509 total
  • Exercise/Conversion

    Common Stock

    2026-01-01+7,11050,619 total
  • Exercise/Conversion

    Common Stock

    2026-01-01+2,08452,703 total
  • Tax Payment

    Common Stock

    2026-01-01$102.14/sh12,479$1,274,60540,224 total
  • Exercise/Conversion

    Performance-Based Restricted Stock Units

    2026-01-0110,5200 total
    Exercise: $0.00Common Stock (10,520 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2026-01-013,32423,268 total
    Exercise: $0.00Common Stock (3,324 underlying)
  • Exercise/Conversion

    Performance-Based Restricted Stock Units

    2026-01-017,1107,110 total
    Exercise: $0.00Common Stock (7,110 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2026-01-012,0846,253 total
    Exercise: $0.00Common Stock (2,084 underlying)
Holdings
  • Performance-Based Restricted Stock Units

    Exercise: $0.00Common Stock (10,520 underlying)
    10,520
Footnotes (6)
  • [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  • [F2]This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026.
  • [F3]Not applicable for Restricted Stock Units.
  • [F4]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  • [F5]This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.
  • [F6]This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Issuer

Guardant Health, Inc.

CIK 0001576280

Entity typeother

Related Parties

1
  • filerCIK 0001702824

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:57 PM ET
Size
20.9 KB